Related Experiment Video

Updated: Aug 24, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Girolline, an antitumor compound isolated from a sponge, induces G2/M cell cycle arrest and accumulation of

Sachiko Tsukamoto1, Katsumi Yamashita, Kazuhiro Tane

  • 1Faculty of Pharmaceutical Sciences, Kanazawa University, Japan. sachiko@p.kanazawa-u.ac.jp

Biological & Pharmaceutical Bulletin
|May 11, 2004
PubMed

Insights

Girolline, an antitumor compound, causes G2/M cell cycle arrest by accumulating p53. This suggests girolline specifically targets the recruitment of polyubiquitinated p53 to the proteasome.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Girolline is an antitumor compound from a sponge.
  • It was previously shown to inhibit protein synthesis termination in vivo.

Purpose of the Study:

  • To investigate the mechanism of girolline's antitumor activity.
  • To determine the specific cellular targets and pathways affected by girolline.

Main Methods:

  • Cell cycle analysis (G2/M arrest) in tumor cell lines.
  • Immunochemical analysis of protein ubiquitination and accumulation.
  • In vitro proteasome activity assays.
  • Experiments using leptomycin B to assess nuclear export inhibition.

Main Results:

  • Girolline induced G2/M cell cycle arrest in multiple tumor cell lines.
  • Accumulation of polyubiquitinated p53 was observed, but not other polyubiquitinated proteins, indicating specificity for p53.
  • Girolline did not inhibit proteasome activity in vitro.
  • Reduced p53 accumulation in the presence of leptomycin B suggested a role for nuclear export.

Conclusions:

  • Girolline's antitumor effect is linked to specific p53 accumulation.
  • The compound appears to interfere with the recruitment of polyubiquitinated p53 to the proteasome, rather than proteasome activity itself.
  • Further research into this mechanism could reveal new therapeutic strategies for cancer.

More Related Videos

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay05:17

Functionalized Spirocyclic Heterocycle Synthesis and Cytotoxicity Assay

Published on: February 9, 2021

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...